Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Research Report 2020 by Manufacturers, Regions, Types and Applications

Table of Contents

1 Report Overview
    1.1 Definition and Specification
    1.2 Report Overview
        1.2.1 Manufacturers Overview
        1.2.2 Regions Overview
        1.2.3 Type Overview
        1.2.4 Application Overview
    1.3 Industrial Chain
        1.3.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Overall Industrial Chain
        1.3.2 Upstream
        1.3.3 Downstream
    1.4 Industry Situation
        1.4.1 Industrial Policy
        1.4.2 Product Preference
        1.4.3 Economic/Political Environment
    1.5 SWOT Analysis
2 Market Analysis by Types
    2.1 Overall Market Performance
        2.1.1 Product Type Market Performance (Volume)
        2.1.2 Product Type Market Performance (Value)
    2.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance
    2.3 USA Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance
    2.4 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance
    2.5 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance
    2.6 Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance
    2.7 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance
    2.8 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance
    2.9 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance
3 Product Application Market
    3.1 Overall Market Performance (Volume)
    3.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance (Volume)
    3.3 USA Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance (Volume)
    3.4 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance (Volume)
    3.5 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance (Volume)
    3.6 Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance (Volume)
    3.7 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance (Volume)
    3.8 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance (Volume)
    3.9 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance (Volume)
4 Manufacturers Profiles/Analysis
    4.1   Astellas Pharmaceuticals 
        4.1.1   Astellas Pharmaceuticals Profiles 
        4.1.2   Astellas Pharmaceuticals Product Information 
        4.1.3   Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Performance  
        4.1.4   Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Development and Market Status  
    4.2   Actavis 
        4.2.1   Actavis Profiles 
        4.2.2   Actavis Product Information 
        4.2.3   Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Performance  
        4.2.4   Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Development and Market Status  
    4.3   Pfizer 
        4.3.1   Pfizer Profiles 
        4.3.2   Pfizer Product Information 
        4.3.3   Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Performance  
        4.3.4   Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Development and Market Status  
    4.4   GlaxoSmithKline 
        4.4.1   GlaxoSmithKline Profiles 
        4.4.2   GlaxoSmithKline Product Information 
        4.4.3   GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Performance  
        4.4.4   GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Development and Market Status  
    4.5   Salix Pharmaceuticals Ltd 
        4.5.1   Salix Pharmaceuticals Ltd Profiles 
        4.5.2   Salix Pharmaceuticals Ltd Product Information 
        4.5.3   Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Performance  
        4.5.4   Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Development and Market Status  
    4.6   AstraZenenca 
        4.6.1   AstraZenenca Profiles 
        4.6.2   AstraZenenca Product Information 
        4.6.3   AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Performance  
        4.6.4   AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Business Development and Market Status  
    4.20  
5 Market Performance for Manufacturers
    5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units) and Market Share by Manufacturers 2015 to 2020
    5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (M USD) and Market Share by Manufacturers 2015 to 2020
    5.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit) of Manufacturers 2015 to 2020
    5.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Gross Margin of Manufacturers 2015 to 2020
    5.5 Market Concentration
6 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance (Production Point)
    6.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units) and Market Share by Regions 2015 to 2020
    6.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (M USD) and Market Share by Regions 2015 to 2020
    6.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit) by Regions 2015 to 2020
    6.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Gross Margin by Regions 2015 to 2020
7 Development Trend for Regions (Production Point)
    7.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units), Revenue (&$B$8&) and Growth Rate 2015 to 2020
    7.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units), Revenue (M USD) and Growth Rate 2015 to 2020
    7.3 USA Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units), Revenue (M USD) and Growth Rate 2015 to 2020
    7.4 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units), Revenue (M USD) and Growth Rate 2015 to 2020
    7.5 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units), Revenue (M USD) and Growth Rate 2015 to 2020
    7.6 Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units), Revenue (M USD) and Growth Rate 2015 to 2020
    7.7 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units), Revenue (M USD) and Growth Rate 2015 to 2020
    7.8 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units), Revenue (M USD) and Growth Rate 2015 to 2020
    7.9 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units), Revenue (M USD) and Growth Rate 2015 to 2020
8 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Performance (Consumption Point)
    8.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Market Share by Regions 2015 to 2020
    8.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value and Market Share by Regions 2015 to 2020
    8.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit) by Regions 2015 to 2020
9 Development Trend for Regions (Sales Point)
    9.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth, Sales Value and Growth Rate2015 to 2020
    9.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth, Sales Value and Growth Rate2015 to 2020
    9.3 USA Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth, Sales Value and Growth Rate2015 to 2020
    9.4 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth, Sales Value and Growth Rate2015 to 2020
    9.5 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth, Sales Value and Growth Rate2015 to 2020
    9.6 Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth, Sales Value and Growth Rate2015 to 2020
    9.7 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth, Sales Value and Growth Rate2015 to 2020
    9.8 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth, Sales Value and Growth Rate2015 to 2020
    9.9 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth, Sales Value and Growth Rate2015 to 2020
10 Upstream Source, Technology and Cost
    10.1 Upstream Source
    10.2 Technology
    10.3 Cost
11 Channel Analysis
    11.1 Market Channel
    11.2 Distributors
12 Consumer Analysis
    12.1 Hospitals Industry 
    12.2   Clinics Industry 
    12.3   Others Industry 
13 Market Forecast 2019-2024
    13.1 Production (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
        13.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
        13.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units) and Growth Rate 2019-2024
        13.1.3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
        13.1.4 USA Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
        13.1.5 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
        13.1.6 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
        13.1.7 Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
        13.1.8 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
        13.1.9 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
        13.1.10 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
    13.2 Sales, Sales Value and Growth Rate 2019-2024
        13.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Market Share by Regions 2019-2024
        13.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Sales Value and Growth Rate 2019-2024
        13.2.3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Sales Value and Growth Rate 2019-2024
        13.2.4 USA Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Sales Value and Growth Rate 2019-2024
        13.2.5 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Sales Value and Growth Rate 2019-2024
        13.2.6 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Sales Value and Growth Rate 2019-2024
        13.2.7 Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Sales Value and Growth Rate 2019-2024
        13.2.8 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Sales Value and Growth Rate 2019-2024
        13.2.9 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Sales Value and Growth Rate 2019-2024
        13.2.10 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Sales Value and Growth Rate 2019-2024
    13.3 Production (K Units), Revenue (M USD) by Types 2019-2024
        13.3.1 Overall Market Performance
        13.3.2 Preface Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
        13.3.3   Eluxadoline Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
        13.3.4   Alosetron Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
        13.3.5   Rifaximin Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
    13.4 Sales by Application 2019-2024
        13.4.1 Overall Market Performance
        13.4.2 Hospitals Sales and and Growth Rate 2019-2024
        13.4.3   Clinics Sales and and Growth Rate 2019-2024
        13.4.4   Others Sales and and Growth Rate 2019-2024
    13.5 Price (USD/Unit) and Gross Profit
        13.5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit) Trend 2019-2024
        13.5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Gross Profit Trend 2019-2024
14 Conclusion